Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hyatt Hotels Corp (Class A) | Thomas J. Pritzker | Director, Ten Percent Owner, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 29 May 2025 | 5,000,000 | 14,369,804 | - | - | Class B Common Stock | |
| Solesence Inc | Bradford T. Whitmore | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 29 May 2025 | 4,189,000 | 30,373,270 | - | 4.2 | 17,593,800 | Common Stock |
| Solesence Inc | Bradford T. Whitmore | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.20 per share. | 29 May 2025 | 4,189,000 | 18,669,879 | - | 4.2 | 17,593,800 | Common Stock |
| Solesence Inc | Bradford T. Whitmore | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 29 May 2025 | 2,500,000 | 26,184,270 | - | 4.2 | 10,500,000 | Common Stock |
| Solesence Inc | Bradford T. Whitmore | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.20 per share. | 29 May 2025 | 2,500,000 | 22,858,879 | - | 4.2 | 10,500,000 | Common Stock |
| Biosig Tech Inc | Anthony Amato | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 900,000 | 3,031,547 (11%) | 3% | 0 | Common Stock | |
| Kyndryl Holdings Inc | Martin J. Schroeter | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 680,419 | 2,085,050 | - | 0 | Common Stock | |
| Braze Inc (Class A) | Neeraj Agrawal | Director | 29 May 2025 | 605,256 | 1,639,369 | - | - | Class B Common Stock | ||
| Braze Inc (Class A) | Neeraj Agrawal | Director | 29 May 2025 | 605,256 | 677,940 | - | - | Class A Common Stock | ||
| Braze Inc (Class A) | Neeraj Agrawal | Director | 29 May 2025 | 582,572 | 1,577,922 | - | - | Class B Common Stock | ||
| Braze Inc (Class A) | Neeraj Agrawal | Director | 29 May 2025 | 582,572 | 652,535 | - | - | Class A Common Stock | ||
| Loews | Laurence A. Tisch | DIRECTOR EMERITUS | Other type of transaction at price $ 88.39 per share. | 29 May 2025 | 565,706 | 13,059,642 (4%) | 0% | 88.4 | 50,002,753 | Common Stock |
| Loews | Laurence A. Tisch | DIRECTOR EMERITUS | Other type of transaction at price $ 88.39 per share. | 29 May 2025 | 565,706 | 551,317 (0%) | 0% | 88.4 | 50,002,753 | Common Stock |
| Angi Inc (Class A) | Jeffrey W. Kip | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 500,000 | 500,000 | - | - | Options to Purchase Class A Common Stock, par value $0.001 | |
| Angi Inc (Class A) | Joseph M. Levin | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 500,000 | 500,000 | - | - | Options to Purchase Class A Common Stock, par value $0.001 | |
| Kyndryl Holdings Inc | Elly Keinan | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 492,495 | 1,289,416 | - | 0 | Common Stock | |
| United Fire Grp Inc | Scott Mcintyre | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 29 May 2025 | 449,675 | 0 (0%) | 1% | - | UFCS Common Stock | |
| Kyndryl Holdings Inc | Martin J. Schroeter | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.76 per share. | 29 May 2025 | 347,356 | 1,737,694 | - | 38.8 | 13,463,519 | Common Stock |
| Allstate | Thomas J. Wilson | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.32 per share. | 29 May 2025 | 295,324 | 295,324 (0%) | 0% | 62.3 | 18,404,592 | Common Stock |
| Allstate | Thomas J. Wilson | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 295,324 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Loews | James S. Tisch | Director | Other type of transaction at price $ 88.39 per share. | 29 May 2025 | 282,852 | 2,818,477 (0%) | 0% | 88.4 | 25,001,288 | Common Stock |
| Loews | James S. Tisch | Director | Other type of transaction at price $ 88.39 per share. | 29 May 2025 | 282,852 | 9,834,259 (3%) | 0% | 88.4 | 25,001,288 | Common Stock |
| Kyndryl Holdings Inc | Elly Keinan | Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.76 per share. | 29 May 2025 | 272,351 | 1,017,065 | - | 38.8 | 10,556,325 | Common Stock |
| Edesa Biotech Inc | Pardeep Nijhawan | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 263,200 | 442,123 (4%) | 2% | 0 | Common Shares | |
| Kyndryl Holdings Inc | David B. Wyshner | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 259,208 | 767,434 | - | 0 | Common Stock | |
| RAPT Therapeutics Inc | Michael F. Giordano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 257,832 | 257,832 | - | - | Director Stock Option (right to buy) | |
| RAPT Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 257,832 | 257,832 | - | - | Director Stock Option (right to buy) | |
| RAPT Therapeutics Inc | Lori Lyons-Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 257,832 | 257,832 | - | - | Director Stock Option (right to buy) | |
| RAPT Therapeutics Inc | Linda Kozick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 257,832 | 257,832 | - | - | Director Stock Option (right to buy) | |
| Edesa Biotech Inc | Michael Brooks | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 207,201 | 224,870 (2%) | 2% | 0 | Common Shares | |
| Asana Inc (Class A) | Eleanor Lacey | GC, Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 175,896 | 516,890 | - | 0 | Class A Common Stock | |
| Biosig Tech Inc | Ferdinand Groenewald | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 175,000 | 235,000 (0%) | 0% | 0 | Common Stock | |
| Coupang Inc (Class A) | Gaurav Anand | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 28.11 per share. | 29 May 2025 | 175,000 | 2,092,290 | - | 28.1 | 4,919,635 | Class A Common Stock |
| PaySign Inc | Mark R. Newcomer | Director, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.51 per share. | 29 May 2025 | 168,000 | 8,768,886 (18%) | 0% | 4.5 | 757,546 | Common Stock |
| Travelers Companies | Alan D. Schnitzer | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 140.85 per share. | 29 May 2025 | 162,927 | 425,256 (0%) | 0% | 140.9 | 22,948,268 | Common Stock |
| Travelers Companies | Alan D. Schnitzer | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 162,927 | 0 | - | - | Stock Options (Right to Buy) | |
| Braze Inc (Class A) | Neeraj Agrawal | Director | 29 May 2025 | 153,928 | 416,920 | - | - | Class B Common Stock | ||
| Braze Inc (Class A) | Neeraj Agrawal | Director | 29 May 2025 | 153,928 | 172,413 | - | - | Class A Common Stock | ||
| Sphere 3D Corp | Duncan J. McEwan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 149,500 | 149,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| Asana Inc (Class A) | Sonalee Parekh | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 144,952 | 1,271,079 | - | 0 | Class A Common Stock | |
| Surf Air Mobility Inc | Sudhin Shahani | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 29 May 2025 | 143,622 | 625,418 | - | 0 | Common Stock | |
| Adial Pharma Inc | Cary J Claiborne | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 138,000 | 138,000 | - | - | Stock Option (Right to Buy) | |
| Kyndryl Holdings Inc | David B. Wyshner | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.76 per share. | 29 May 2025 | 132,587 | 634,847 | - | 38.8 | 5,139,072 | Common Stock |
| Braze Inc (Class A) | Neeraj Agrawal | Director | 29 May 2025 | 131,244 | 355,473 | - | - | Class B Common Stock | ||
| Braze Inc (Class A) | Neeraj Agrawal | Director | 29 May 2025 | 131,244 | 147,008 | - | - | Class A Common Stock | ||
| Asana Inc (Class A) | Anne Raimondi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 130,294 | 846,874 | - | 0 | Class A Common Stock | |
| Keurig Dr Pepper | Eric Gorli | President, US Refreshment Bev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 128,551 | 128,551 | - | - | Restricted Stock Unit | |
| Travelers Companies | Alan D. Schnitzer | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 274.48 per share. | 29 May 2025 | 127,471 | 297,785 (0%) | 0% | 274.5 | 34,988,368 | Common Stock |
| Sphere 3D Corp | Timothy P. Hanley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 126,300 | 126,300 | - | - | Restricted Stock Unit (RSU) | |
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 125,862 | 125,862 | - | - | Director stock option (right to buy) | |
| ProKidney Corp Ordinary | William F. Doyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 125,862 | 125,862 | - | - | Director stock option (right to buy) | |
| ProKidney Corp Ordinary | Alan M. Lotvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 125,862 | 125,862 | - | - | Director stock option (right to buy) | |
| ProKidney Corp Ordinary | Uma Sinha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 125,862 | 125,862 | - | - | Director stock option (right to buy) | |
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 125,862 | 125,862 | - | - | Director stock option (right to buy) | |
| ProKidney Corp Ordinary | Jennifer A. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 125,862 | 125,862 | - | - | Director stock option (right to buy) | |
| ProKidney Corp Ordinary | Jose Ignacio Jimenez Santos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 125,862 | 125,862 | - | - | Director stock option (right to buy) | |
| Stem Inc (Class A) | Ira M. Birns | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 110,236 | 0 | - | - | Restricted Stock Unit | |
| Stem Inc (Class A) | Ira M. Birns | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 110,236 | 134,420 | - | 0 | Common Stock, Par Value $0.0001 Per Share | |
| Stem Inc (Class A) | Adam E. Daley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 110,236 | 240,996 | - | 0 | Common Stock, Par Value $0.0001 Per Share | |
| Stem Inc (Class A) | Adam E. Daley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 110,236 | 0 | - | - | Restricted Stock Unit | |
| Stem Inc (Class A) | Anil Tammineedi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 110,236 | 0 | - | - | Restricted Stock Unit | |
| Stem Inc (Class A) | Anil Tammineedi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 110,236 | 159,747 | - | 0 | Common Stock, Par Value $0.0001 Per Share | |
| Fate Therapeutics Inc | Matthew C. Abernethy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 107,400 | 107,400 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Robert Sanders Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 107,400 | 107,400 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Jeffrey T. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 107,400 | 107,400 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Karah Parschauer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 107,400 | 107,400 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | June Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 107,400 | 107,400 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Catherine Stehman-Breen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 107,400 | 107,400 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 107,400 | 107,400 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Deepak Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 107,400 | 107,400 | - | - | Stock Option (Right to buy) | |
| Jefferies Fin Grp Inc | Richard B. Handler | Director, CEO | Grant, award, or other acquisition of securities at price $ 49.41 per share. | 29 May 2025 | 102,801 | 13,438,617 (4%) | 0% | 49.4 | 5,079,397 | Common Stock |
| Getty Images Holdings Inc (Class A) | Mikael Cho | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 102,360 | 209,558 | - | 0 | Class A Common Stock | |
| Getty Images Holdings Inc (Class A) | Jerry Jenkins | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 101,352 | 101,352 | - | 0 | Class A Common Stock | |
| Village Farms Intl Inc | Michael A. DeGiglio | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 29 May 2025 | 100,000 | 9,758,127 (18%) | 0% | 1.2 | 120,500 | Common Shares |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 29 May 2025 | 100,000 | 10,402,108 | - | 0 | Class A Common Stock | |
| Oklo Inc (Class A) | Jacob DeWitte | Director, Co-Founder, CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 29 May 2025 | 100,000 | 10,705,098 | - | 0 | Class A Common Stock | |
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 29 May 2025 | 100,000 | 10,705,098 | - | 0 | Class A Common Stock | |
| Oklo Inc (Class A) | Caroline Cochran | Director, Co-Founder, COO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 29 May 2025 | 100,000 | 10,402,108 | - | 0 | Class A Common Stock | |
| Kyndryl Holdings Inc | Edward Sebold | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 97,204 | 230,022 | - | 0 | Common Stock | |
| Adial Pharma Inc | Tony Goodman | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 94,000 | 94,000 | - | - | Stock Option (Right to Buy) | |
| TeraWulf Inc | Paul B. Prager | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 29 May 2025 | 94,000 | 491,700 | - | - | Common stock, $0.001 par value per share | |
| Elutia Inc (Class A) | Kevin Rakin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 90,509 | 90,509 | - | - | Stock Option (Right to Buy) | |
| Allstate | Thomas J. Wilson | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 206.45 per share. | 29 May 2025 | 89,149 | 206,175 (0%) | 0% | 206.4 | 18,404,811 | Common Stock |
| Esperion Therapeutics Inc | Nicole Vitullo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 88,000 | 88,000 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc | Tracy M. Woody | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 88,000 | 88,000 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Mannix Vartan Aklian | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 84,375 | 84,375 | - | - | Stock Option (right to buy) | |
| Workiva Inc (Class A) | Martin J. Vanderploeg | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 29 May 2025 | 84,210 | 314,489 (0%) | 0% | 0 | Class A Common Stock | |
| Workiva Inc (Class A) | Martin J. Vanderploeg | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 29 May 2025 | 84,210 | 439,885 (1%) | 0% | 0 | Class A Common Stock | |
| Nextracker Inc (Class A) | Bruce R. Ledesma | Chief Legal & Compliance Ofc | Sale of securities on an exchange or to another person at price $ 55.71 per share. | 29 May 2025 | 83,561 | 195,790 | - | 55.7 | 4,655,434 | Common Stock |
| Rafael Holdings Inc (Class B) | David Polinsky | Chief Financial Officer | 29 May 2025 | 76,882 | 0 | - | - | Class B Common Stock | ||
| Rafael Holdings Inc (Class B) | David Polinsky | Chief Financial Officer | 29 May 2025 | 76,882 | 270,422 (1%) | 0% | 1.3 | 98,409 | Class B Common Stock, par value $.01 per share | |
| Entravision Comm Corp (Class A) | Gilbert R. Vasquez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 74,879 | 954,255 (1%) | 0% | 0 | Class A common stock | |
| Entravision Comm Corp (Class A) | Paul A. Zevnik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 74,879 | 206,148 (0%) | 0% | 0 | Class A common stock | |
| Entravision Comm Corp (Class A) | Lara Sweet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 74,879 | 173,246 (0%) | 0% | 0 | Class A common stock | |
| Entravision Comm Corp (Class A) | Martha Elena Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 74,879 | 336,037 (0%) | 0% | 0 | Class A common stock | |
| Entravision Comm Corp (Class A) | Fehmi Zeko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 74,879 | 294,047 (0%) | 0% | 0 | Class A common stock | |
| Entravision Comm Corp (Class A) | Thomas Strickler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 74,879 | 189,241 (0%) | 0% | 0 | Class A common stock | |
| Entravision Comm Corp (Class A) | Brad Bender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 74,879 | 179,241 (0%) | 0% | 0 | Class A common stock | |
| Perella Weinberg Partners | Robert K. Steel | Director | Sale of securities on an exchange or to another person at price $ 17.73 per share. | 29 May 2025 | 73,107 | 250,075 | - | 17.7 | 1,296,187 | Class A Common Stock |
| Asana Inc (Class A) | Anne Raimondi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 70,078 | 916,952 | - | 0 | Class A Common Stock | |
| Asana Inc (Class A) | Eleanor Lacey | GC, Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 70,078 | 586,968 | - | 0 | Class A Common Stock | |
| Asana Inc (Class A) | Sonalee Parekh | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 70,078 | 1,341,157 | - | 0 | Class A Common Stock | |
| Kyverna Therapeutics Inc | Beth C. Seidenberg | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 65,351 | 65,351 | - | - | Stock Option (right to buy) | |
| Kyverna Therapeutics Inc | Daniel K. Spiegelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 65,351 | 65,351 | - | - | Stock Option (right to buy) | |
| Kyverna Therapeutics Inc | Fred E. Cohen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 65,351 | 65,351 | - | - | Stock Option (right to buy) | |
| Kyverna Therapeutics Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 65,351 | 65,351 | - | - | Stock Option (right to buy) | |
| Kyverna Therapeutics Inc | Christi Shaw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 65,351 | 65,351 | - | - | Stock Option (right to buy) | |
| Kyverna Therapeutics Inc | Mert Aktar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 65,351 | 65,351 | - | - | Stock Option (right to buy) | |
| Edesa Biotech Inc | Peter J. Weiler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 65,000 | 65,000 (0%) | 0% | 0 | Common Shares | |
| Kyndryl Holdings Inc | Maryjo T Charbonnier | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 64,803 | 181,164 | - | 0 | Common Stock | |
| Travelers Companies | Avrohom J. Kess | Vice Chmn & Chief Legal Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 118.78 per share. | 29 May 2025 | 63,155 | 111,542 (0%) | 0% | 118.8 | 7,501,551 | Common Stock |
| Travelers Companies | Avrohom J. Kess | Vice Chmn & Chief Legal Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 63,155 | 0 | - | - | Stock Options (Right to Buy) | |
| Perella Weinberg Partners | Robert K. Steel | Director | Sale of securities on an exchange or to another person at price $ 17.45 per share. | 29 May 2025 | 62,997 | 187,078 | - | 17.5 | 1,099,298 | Class A Common Stock |
| Stem Inc (Class A) | Vasudevan Guruswamy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 62,222 | 62,222 | - | 0 | Common Stock, Par Value $0.0001 Per Share | |
| Stem Inc (Class A) | Vasudevan Guruswamy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 62,222 | 0 | - | - | Restricted Stock Unit | |
| Stem Inc (Class A) | Krishna Shivram | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 62,222 | 62,222 | - | 0 | Common Stock, Par Value $0.0001 Per Share | |
| Stem Inc (Class A) | Krishna Shivram | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 62,222 | 0 | - | - | Restricted Stock Unit | |
| Elutia Inc (Class A) | Brigid A. Makes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 60,339 | 60,339 | - | - | Stock Option (Right to Buy) | |
| Elutia Inc (Class A) | Maybelle Jordan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 60,339 | 60,339 | - | - | Stock Option (Right to Buy) | |
| Elutia Inc (Class A) | David Colpman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 60,339 | 60,339 | - | - | Stock Option (Right to Buy) | |
| Perella Weinberg Partners | Robert K. Steel | Director | Sale of securities on an exchange or to another person at price $ 17.30 per share. | 29 May 2025 | 60,092 | 126,986 | - | 17.3 | 1,039,592 | Class A Common Stock |
| HeartCore Enterprises Inc | Daishin Yasui | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.70 per share. | 29 May 2025 | 60,000 | 2,201,756 | - | 0.7 | 42,000 | Common Stock |
| Somnigroup Intl Inc | Peter R. Sachse | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 29 May 2025 | 60,000 | 63,290 (0%) | 0% | 0 | Common Stock | |
| Somnigroup Intl Inc | Peter R. Sachse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 60,000 | 60,000 (0%) | 0% | 0 | Common Stock | |
| Keurig Dr Pepper | Anthony Shoemaker | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 59,791 | 59,791 | - | - | Restricted Stock Unit | |
| Fate Therapeutics Inc | William H. Rastetter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Robert S. Epstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | John D. Mendlein | Director | 29 May 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | ||
| Fate Therapeutics Inc | Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Karin Jooss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Neelufar Mozaffarian | Director | 29 May 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | ||
| Fate Therapeutics Inc | Michael Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Zura Bio Ltd (Class A) | Daniel Becker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 51,000 | 51,000 | - | - | Share Option (Right to Buy) | |
| HeartCore Enterprises Inc | Daishin Yasui | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 29 May 2025 | 50,000 | 2,261,756 | - | 0.7 | 33,440 | Common Stock |
| Getty Images Holdings Inc (Class A) | Craig Peters | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 50,000 | 1,312,948 | - | 0 | Class A Common Stock | |
| Kyndryl Holdings Inc | Edward Sebold | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.76 per share. | 29 May 2025 | 48,937 | 181,085 | - | 38.8 | 1,896,798 | Common Stock |
| Kyndryl Holdings Inc | Vineet Khurana | SVP & Global Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 48,603 | 92,480 | - | 0 | Common Stock | |
| Travelers Companies | Avrohom J. Kess | Vice Chmn & Chief Legal Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 272.93 per share. | 29 May 2025 | 47,211 | 64,331 (0%) | 0% | 272.9 | 12,885,298 | Common Stock |
| Core Scientific Inc - Ordinary Shares - New | Elizabeth Crain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 46,773 | 46,773 | - | 0 | Common Stock | |
| Esperion Therapeutics Inc | Stephen C. Rocamboli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc | J. Martin Carroll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Quoin Pharma Ltd (ADR) | Michael Myers | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 42,857 | 42,857 | - | - | Share Option (Right to Buy) | |
| Quoin Pharma Ltd (ADR) | Denise Carter | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 42,857 | 42,857 | - | - | Share Option (Right to Buy) | |
| Duluth Holdings Inc (Class B) | Ronald Robinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 42,554 | 74,973 (0%) | 0% | - | Class B Common Stock | |
| Duluth Holdings Inc (Class B) | Susan J. Riley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 42,554 | 82,556 (0%) | 0% | - | Class B Common Stock | |
| Duluth Holdings Inc (Class B) | Scott K. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 42,554 | 114,486 (0%) | 0% | - | Class B Common Stock | |
| Duluth Holdings Inc (Class B) | David C. Finch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 42,554 | 207,480 (0%) | 0% | - | Class B Common Stock | |
| Duluth Holdings Inc (Class B) | Janet H. Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 42,554 | 93,421 (0%) | 0% | - | Class B Common Stock | |
| Duluth Holdings Inc (Class B) | Brett L. Paschke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 42,554 | 136,355 (0%) | 0% | - | Class B Common Stock | |
| C3.ai Inc (Class A) | Stephen M. Ward | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.68 per share. | 29 May 2025 | 42,382 | 588,877 | - | 4.7 | 198,348 | Class A Common Stock |
| C3.ai Inc (Class A) | Stephen M. Ward | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 42,382 | 10,196 | - | - | Stock Option (Right to Buy) | |
| C3.ai Inc (Class A) | Stephen M. Ward | Director | Sale of securities on an exchange or to another person at price $ 26.32 per share. | 29 May 2025 | 42,382 | 546,495 | - | 26.3 | 1,115,494 | Class A Common Stock |
| Quoin Pharma Ltd (ADR) | Michael Myers | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 42,039 | 42,039 | - | - | Share Option (Right to Buy) | |
| Quoin Pharma Ltd (ADR) | Denise Carter | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 42,039 | 42,039 | - | - | Share Option (Right to Buy) | |
| Remitly Global Inc | Joshua Hug | Director | Sale of securities on an exchange or to another person at price $ 21.14 per share. | 29 May 2025 | 40,777 | 3,753,811 | - | 21.1 | 862,026 | Common Stock |
| Getty Images Holdings Inc (Class A) | Daine Marc Weston | Senior VP, Ecommerce | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 40,010 | 146,857 | - | 0 | Class A Common Stock | |
| Amphenol (Class A) | Michael R. Ivas | VP & Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 40,000 | 50,000 | - | - | Stock Option | |
| Amphenol (Class A) | Michael R. Ivas | VP & Corporate Controller | Sale of securities on an exchange or to another person at price $ 88.79 per share. | 29 May 2025 | 40,000 | 152,412 (0%) | 0% | 88.8 | 3,551,408 | Class A Common Stock |
| Amphenol (Class A) | Michael R. Ivas | VP & Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.23 per share. | 29 May 2025 | 40,000 | 192,412 (0%) | 0% | 18.2 | 729,200 | Class A Common Stock |
| Rollins | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 56.77 per share. | 29 May 2025 | 40,000 | 662,727 (0%) | 0% | 56.8 | 2,270,800 | Common Stock |
| Massimo Grp | David Shan | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 37,500 | 32,160,000 | - | 0 | Common Stock | |
| Box Inc (Class A) | Daniel J. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 37,499 | 0 | - | - | Employee Stock Option (right to buy) | |
| Box Inc (Class A) | Daniel J. Levin | Director | Sale of securities on an exchange or to another person at price $ 36.74 per share. | 29 May 2025 | 37,499 | 0 (0%) | 0% | 36.7 | 1,377,826 | Class A Common Stock |
| Box Inc (Class A) | Daniel J. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.52 per share. | 29 May 2025 | 37,499 | 37,499 (0%) | 0% | 17.5 | 656,982 | Class A Common Stock |
| Black Stone Minerals L.P. - Unit | Carrie P. Clark | SVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 13.56 per share. | 29 May 2025 | 36,900 | 165,857 (0%) | 0% | 13.6 | 500,338 | Common units representing limited partner interests |
| Travelers Companies | Maria Olivo | EVP, Strat Dev & Pres Intl | Sale of securities on an exchange or to another person at price $ 274.20 per share. | 29 May 2025 | 36,199 | 118,116 (0%) | 0% | 274.2 | 9,925,639 | Common Stock |
| Travelers Companies | Maria Olivo | EVP, Strat Dev & Pres Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 36,199 | 0 | - | - | Stock Option (Right to Buy) | |
| Travelers Companies | Maria Olivo | EVP, Strat Dev & Pres Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 106.03 per share. | 29 May 2025 | 36,199 | 154,315 (0%) | 0% | 106.0 | 3,838,180 | Common Stock |
| C3.ai Inc (Class A) | Richard C. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.68 per share. | 29 May 2025 | 36,000 | 197,664 | - | 4.7 | 168,480 | Class A Common Stock |
| C3.ai Inc (Class A) | Richard C. Levin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 36,000 | 3,955 | - | - | Stock Option (Right to Buy) | |
| Kyndryl Holdings Inc | Maryjo T Charbonnier | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.76 per share. | 29 May 2025 | 33,083 | 148,081 | - | 38.8 | 1,282,297 | Common Stock |
| Esperion Therapeutics Inc | Stephen C. Rocamboli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 33,000 | 69,261 (0%) | 0% | 0 | Common Stock | |
| Esperion Therapeutics Inc | Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 33,000 | 84,599 (0%) | 0% | 0 | Common Stock | |
| Esperion Therapeutics Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 33,000 | 61,150 (0%) | 0% | 0 | Common Stock | |
| Esperion Therapeutics Inc | J. Martin Carroll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 33,000 | 97,650 (0%) | 0% | 0 | Common Stock | |
| Sunopta Inc | Jennifer Ann Caro | SVP, Sale | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 32,967 | 32,967 | - | - | Restricted Stock Units | |
| Jefferies Fin Grp Inc | Brian P. Friedman | Director, President | Grant, award, or other acquisition of securities at price $ 49.41 per share. | 29 May 2025 | 31,685 | 2,472,007 (0%) | 0% | 49.4 | 1,565,556 | Common Stock |
| Travelers Companies | Avrohom J. Kess | Vice Chmn & Chief Legal Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 122.42 per share. | 29 May 2025 | 30,358 | 94,689 (0%) | 0% | 122.4 | 3,716,426 | Common Stock |
| Travelers Companies | Avrohom J. Kess | Vice Chmn & Chief Legal Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 30,358 | 0 | - | - | Stock Options (Right to Buy) | |
| Urban Outfitters Inc | Margaret A. Hayne | Director, Co-President & CCO | Sale of securities on an exchange or to another person at price $ 72.39 per share. | 29 May 2025 | 30,133 | 108,090 (0%) | 0% | 72.4 | 2,181,448 | Common Shares |
| Urban Outfitters Inc | Margaret A. Hayne | Director, Co-President & CCO | Sale of securities on an exchange or to another person at price $ 72.39 per share. | 29 May 2025 | 30,133 | 97,217 (0%) | 0% | 72.4 | 2,181,448 | Common Shares |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 72.39 per share. | 29 May 2025 | 30,133 | 97,217 (0%) | 0% | 72.4 | 2,181,448 | Common Shares |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 72.39 per share. | 29 May 2025 | 30,133 | 108,090 (0%) | 0% | 72.4 | 2,181,448 | Common Shares |
| Citizens Inc (Class A) | Jon Stenberg | President & CEO | Purchase of securities on an exchange or from another person at price $ 3.69 per share. | 29 May 2025 | 30,000 | 179,016 (0%) | 0% | 3.7 | 110,838 | Citizens, Inc. Class A Common Stock |
| Zevra Therapeutics Inc | Tamara A. Favorito | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Alvin Shih | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Thomas D. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | John B. Bode | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Douglas W. Calder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Corey Watton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| ON24 Inc | Jayesh Sahasi | EV President, Product and CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 29,375 | 772,713 | - | 0 | Common Stock | |
| Diversified Healthcare Trust | Jeffrey P. Somers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 29,141 | 164,678 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Diversified Healthcare Trust | Adam D. Portnoy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 29,141 | 348,607 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Diversified Healthcare Trust | Lisa Harris Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 29,141 | 157,494 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Diversified Healthcare Trust | Christopher J. Bilotto | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 29,141 | 180,821 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Diversified Healthcare Trust | Phyllis M. Hollis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 29,141 | 87,080 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Diversified Healthcare Trust | Dawn K. Neher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 29,141 | 66,178 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Diversified Healthcare Trust | Alan L. Felder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 29,141 | 62,723 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Solid Power Inc (Class A) | Lesa Roe | Director | Sale of securities on an exchange or to another person at price $ 1.69 per share. | 29 May 2025 | 29,000 | 239,049 | - | 1.7 | 49,010 | Common Stock |
| Montana Tech Corp (Class A) | J Kyle Derham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 28,037 | 28,037 | - | - | Restricted Stock Units | |
| Montana Tech Corp (Class A) | Ajay Agrawal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 28,037 | 28,037 | - | - | Restricted Stock Units | |
| Montana Tech Corp (Class A) | Paul M. Dabbar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 28,037 | 28,037 | - | - | Restricted Stock Units | |
| Montana Tech Corp (Class A) | Marwa Zaatari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 28,037 | 28,037 | - | - | Restricted Stock Units | |
| Adial Pharma Inc | J. Kermit Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharma Inc | Robertson H. Gilliland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharma Inc | James W. Newman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharma Inc | Kevin Schuyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| Entergy | Kimberly A. Fontan | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 81.95 per share. | 29 May 2025 | 27,890 | 44,571 (0%) | 0% | 82.0 | 2,285,586 | Common Stock |
| ON24 Inc | Steven Vattuone | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 27,500 | 675,087 | - | 0 | Common Stock | |
| Braze Inc (Class A) | Neeraj Agrawal | Director | 29 May 2025 | 27,000 | 30,241 | - | - | Class A Common Stock | ||
| Braze Inc (Class A) | Neeraj Agrawal | Director | 29 May 2025 | 27,000 | 73,137 | - | - | Class B Common Stock | ||
| Monster Beverage | Thomas J. Kelly | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 63.40 per share. | 29 May 2025 | 27,000 | 69,273 (0%) | 0% | 63.4 | 1,711,800 | Common Stock |
| Seagate Tech | Gianluca Romano | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 26,816 | 5,364 | - | - | NQ Options | |
| Seagate Tech | Gianluca Romano | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.34 per share. | 29 May 2025 | 26,816 | 64,898 (0%) | 0% | 87.3 | 2,342,109 | Ordinary Shares |
| Getty Images Holdings Inc (Class A) | Chris Hoel | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 26,800 | 91,377 | - | 0 | Class A Common Stock | |
| Cogent Comm Holdings Inc | David Schaeffer | Director, CHAIRMAN, CEO, AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 46.90 per share. | 29 May 2025 | 25,000 | 4,086,721 (8%) | 0% | 46.9 | 1,172,593 | common stock |
| Roku Inc (Class A) | Anthony Wood | Director, CEO and Chairman BOD, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 29 May 2025 | 25,000 | 0 (0%) | 0% | 75 | 1,875,000 | Class A Common Stock |
| Roku Inc (Class A) | Anthony Wood | Director, CEO and Chairman BOD, Ten Percent Owner | 29 May 2025 | 25,000 | 25,000 (0%) | 0% | - | Class A Common Stock | ||
| Roku Inc (Class A) | Anthony Wood | Director, CEO and Chairman BOD, Ten Percent Owner | 29 May 2025 | 25,000 | 16,903,111 | - | - | Class B Common Stock | ||
| Getty Images Holdings Inc (Class A) | Grant Farhall | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 292,006 | - | 0 | Class A Common Stock | |
| Getty Images Holdings Inc (Class A) | Gene Foca | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 493,943 | - | 0 | Class A Common Stock | |
| Getty Images Holdings Inc (Class A) | Nathaniel Gandert | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 559,377 | - | 0 | Class A Common Stock | |
| Getty Images Holdings Inc (Class A) | Kjelti Kellough | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 290,803 | - | 0 | Class A Common Stock | |
| Getty Images Holdings Inc (Class A) | Jennifer Leyden | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 303,072 | - | 0 | Class A Common Stock | |
| Getty Images Holdings Inc (Class A) | Peter Orlowsky | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 249,509 | - | 0 | Class A Common Stock | |
| Massimo Grp | Yunhao Chen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 133,334 | - | 0 | Common Stock | |
| Massimo Grp | Michael Smith | Former Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 50,000 | - | 0 | Common Stock | |
| ON24 Inc | James Blackie | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 541,481 | - | 0 | Common Stock | |
| Spyre Therapeutics Inc | Jeffrey W. Albers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Spyre Therapeutics Inc | Laurie D. Stelzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Spyre Therapeutics Inc | Mark C. McKenna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Spyre Therapeutics Inc | Michael Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Spyre Therapeutics Inc | Sandra Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Kyndryl Holdings Inc | Vineet Khurana | SVP & Global Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.76 per share. | 29 May 2025 | 24,794 | 67,686 | - | 38.8 | 961,015 | Common Stock |
| Allstate | Thomas J. Wilson | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 206.37 per share. | 29 May 2025 | 24,715 | 181,460 (0%) | 0% | 206.4 | 5,100,509 | Common Stock |
| Banc of California Inc | Bryan M. Corsini | CHIEF CREDIT OFFICER | Sale of securities on an exchange or to another person at price $ 13.78 per share. | 29 May 2025 | 24,066 | 84,889 (0%) | 0% | 13.8 | 331,726 | Common Stock |
| Roblox Corp (Class A) | Amy Marie Rawlings | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 84.87 per share. | 29 May 2025 | 23,528 | 50,403 | - | 84.9 | 1,996,880 | Class A Common Stock |
| Travelers Companies | Avrohom J. Kess | Vice Chmn & Chief Legal Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 273.26 per share. | 29 May 2025 | 22,868 | 71,821 (0%) | 0% | 273.3 | 6,248,910 | Common Stock |
| Tyra Biosciences Inc | Gilla Kaplan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 22,200 | 22,200 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 22,200 | 22,200 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Susan Moran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 22,200 | 22,200 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Jake Simson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 22,200 | 22,200 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Rehan Verjee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 22,200 | 22,200 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | S. Michael Rothenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 22,200 | 22,200 | - | - | Stock Option (Right to Buy) | |
| Transocean Ltd | Robert Thaddeus Vayda | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.57 per share. | 29 May 2025 | 21,879 | 273,869 (0%) | 0% | 2.6 | 56,229 | Registered Shares |
| Travelers Companies | Alan D. Schnitzer | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 274.03 per share. | 29 May 2025 | 21,335 | 262,329 (0%) | 0% | 274.0 | 5,846,419 | Common Stock |
| Stem Inc (Class A) | Matthew Tappin | President, Software Division | Sale of securities on an exchange or to another person at price $ 0.45 per share. | 29 May 2025 | 20,823 | 37,458 | - | 0.4 | 9,370 | Common Stock, Par Value $0.0001 Per Share |
| CarGurus Inc (Class A) | Langley Steinert | Director, Executive Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.00 per share. | 29 May 2025 | 20,639 | 520,354 (0%) | 0% | 31.0 | 639,906 | Class A Common Stock |
| CarGurus Inc (Class A) | Langley Steinert | Director, Executive Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.51 per share. | 29 May 2025 | 20,639 | 561,632 (0%) | 0% | 31.5 | 650,244 | Class A Common Stock |
| CarGurus Inc (Class A) | Langley Steinert | Director, Executive Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.23 per share. | 29 May 2025 | 20,639 | 540,993 (0%) | 0% | 31.2 | 644,572 | Class A Common Stock |
| Travelers Companies | Daniel S. Frey | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 20,286 | 0 | - | - | Stock Options (Right to Buy) | |
| Travelers Companies | Daniel S. Frey | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 132.58 per share. | 29 May 2025 | 20,286 | 47,217 (0%) | 0% | 132.6 | 2,689,518 | Common Stock |
| Travelers Companies | Daniel S. Frey | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 273.48 per share. | 29 May 2025 | 20,286 | 26,931 (0%) | 0% | 273.5 | 5,547,740 | Common Stock |
| Sprouts Farmers Market Inc | Nicholas Konat | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.05 per share. | 29 May 2025 | 20,270 | 75,945 (0%) | 0% | 32.1 | 649,654 | Common Stock, par value $0.001 per share |
| Sprouts Farmers Market Inc | Nicholas Konat | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 20,270 | 0 | - | - | Stock Option (right to buy) | |
| Sprouts Farmers Market Inc | Nicholas Konat | President & COO | Sale of securities on an exchange or to another person at price $ 167.50 per share. | 29 May 2025 | 20,270 | 55,675 (0%) | 0% | 167.5 | 3,395,152 | Common Stock, par value $0.001 per share |
| Sunopta Inc | Albert D. Bolles | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 20,072 | 226,368 (0%) | 0% | - | Common Shares | |
| Sunopta Inc | Albert D. Bolles | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 20,072 | 0 | - | - | Restricted Stock Units | |
| Sunopta Inc | Richard Dean Hollis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 20,072 | 576,354 (0%) | 0% | - | Common Shares | |
| Sunopta Inc | Richard Dean Hollis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 20,072 | 0 | - | - | Restricted Stock Units | |
| Sunopta Inc | Mahes S. Wickramasinghe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 20,072 | 45,185 (0%) | 0% | - | Common Shares | |
| Sunopta Inc | Mahes S. Wickramasinghe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 20,072 | 0 | - | - | Restricted Stock Units | |
| Sunopta Inc | Leslie Starr Keating | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 20,072 | 0 | - | - | Restricted Stock Units | |
| Sunopta Inc | Leslie Starr Keating | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 20,072 | 127,173 (0%) | 0% | - | Common Shares | |
| Sunopta Inc | Rebecca Fisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 20,072 | 136,083 (0%) | 0% | - | Common Shares | |
| Sunopta Inc | Rebecca Fisher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 20,072 | 0 | - | - | Restricted Stock Units | |
| Sunopta Inc | Diego Reynoso | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 20,072 | 0 | - | - | Restricted Stock Units | |
| Sunopta Inc | Diego Reynoso | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 20,072 | 47,997 (0%) | 0% | - | Common Shares | |
| Edesa Biotech Inc | Sean MacDonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 20,001 | 22,054 (0%) | 0% | 0 | Common Shares | |
| Edesa Biotech Inc | Carlo Sistilli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 20,001 | 30,417 (0%) | 0% | 0 | Common Shares | |
| Lincoln Educational Services Corp | Felecia J. Pryor | Director | Sale of securities on an exchange or to another person at price $ 23.53 per share. | 29 May 2025 | 20,000 | 14,306 (0%) | 0% | 23.5 | 470,600 | Common Stock |
| Clarus Corp | Nicholas Sokolow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 20,000 | 20,000 | - | - | Stock Option (right to purchase) | |
| Clarus Corp | Roger L. Werner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 20,000 | 20,000 | - | - | Stock Option (right to purchase) | |
| Clarus Corp | Mark M. Besca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 20,000 | 20,000 | - | - | Stock Option (right to purchase) | |
| Clarus Corp | Susan Ottmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 20,000 | 20,000 | - | - | Stock Option (right to purchase) | |
| Remitly Global Inc | Joshua Hug | Director | Sale of securities on an exchange or to another person at price $ 21.37 per share. | 29 May 2025 | 20,000 | 3,733,811 | - | 21.4 | 427,400 | Common Stock |
| Remitly Global Inc | Joshua Hug | Director | Sale of securities on an exchange or to another person at price $ 21.07 per share. | 29 May 2025 | 20,000 | 3,713,811 | - | 21.1 | 421,400 | Common Stock |
| Advantage Soln Inc (Class A) | James M. Kilts | Director | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 29 May 2025 | 19,627 | 1,302,726 | - | 1.2 | 24,092 | Class A Common Stock |
| Interface Inc | James Poppens | Vice President | Sale of securities on an exchange or to another person at price $ 20.14 per share. | 29 May 2025 | 19,474 | 130,142 (0%) | 0% | 20.1 | 392,150 | Common Stock |
| Hovnanian Enterprises Inc (Class A) | Ara K. Hovnanian | Director, Chairman of Bd., Pres. & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 19,086 | 38,172 | - | - | Performance Share Units (2024) | |
| ProFrac Holding Corp (Class A) | Gerald W. Haddock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 18,916 | 68,988 | - | 0 | Class A Common Stock, par value $0.01 | |
| ProFrac Holding Corp (Class A) | Stacy Durbin Nieuwoudt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 18,916 | 78,238 | - | 0 | Class A Common Stock, par value $0.01 | |
| ProFrac Holding Corp (Class A) | Theresa Glebocki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 18,916 | 71,988 | - | 0 | Class A Common Stock, par value $0.01 | |
| ProFrac Holding Corp (Class A) | James C. Randle | Director | 29 May 2025 | 18,916 | 662,647 | - | 0 | Class A Common Stock, par value $0.01 | ||
| Topgolf Callaway Brands Corp | Anthony S. Thornley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 18,546 | 18,546 | - | - | Restricted Stock Units | |
| Topgolf Callaway Brands Corp | John F. Lundgren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 18,546 | 18,546 | - | - | Restricted Stock Units | |
| Topgolf Callaway Brands Corp | Erik J. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 18,546 | 18,546 | - | - | Restricted Stock Units | |
| Topgolf Callaway Brands Corp | Russell L. Fleischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 18,546 | 18,546 | - | - | Restricted Stock Units | |
| Topgolf Callaway Brands Corp | Linda B. Segre | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 18,546 | 18,546 | - | - | Restricted Stock Units | |
| Topgolf Callaway Brands Corp | Adebayo O. Ogunlesi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 18,546 | 18,546 | - | - | Restricted Stock Units | |
| Topgolf Callaway Brands Corp | Varsha R. Rao | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 18,546 | 18,546 | - | - | Restricted Stock Units | |
| Topgolf Callaway Brands Corp | Bavan M. Holloway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 18,546 | 18,546 | - | - | Restricted Stock Units | |
| Topgolf Callaway Brands Corp | Scott M. Marimow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 18,546 | 18,546 | - | - | Restricted Stock Units | |
| Topgolf Callaway Brands Corp | C. Matthew Turney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 18,546 | 18,546 | - | - | Restricted Stock Units | |
| e.l.f. Beauty Inc | Jennifer Catherine Hartnett | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 109.99 per share. | 29 May 2025 | 18,383 | 54,163 (0%) | 0% | 110.0 | 2,021,946 | Common Stock |
| Reynolds Consumer Products Inc | Chris Mayrhofer | VP, Controller & CAO | Purchase of securities on an exchange or from another person at price $ 22.14 per share. | 29 May 2025 | 18,217 | 18,217 (0%) | 0% | 22.1 | 403,319 | Common Stock |
| C3.ai Inc (Class A) | Richard C. Levin | Director | Sale of securities on an exchange or to another person at price $ 30.02 per share. | 29 May 2025 | 18,000 | 161,664 | - | 30.0 | 540,360 | Class A Common Stock |
| C3.ai Inc (Class A) | Richard C. Levin | Director | Sale of securities on an exchange or to another person at price $ 26.32 per share. | 29 May 2025 | 18,000 | 179,664 | - | 26.3 | 473,760 | Class A Common Stock |
| Mosaic | Walter F. Precourt | SVP - Chief Admin Officer | Sale of securities on an exchange or to another person at price $ 35.73 per share. | 29 May 2025 | 18,000 | 128,546 (0%) | 0% | 35.7 | 643,140 | Common Stock |
| Sunopta Inc | Albert D. Bolles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 17,770 | 17,770 | - | - | Restricted Stock Units | |
| Sunopta Inc | Richard Dean Hollis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 17,770 | 17,770 | - | - | Restricted Stock Units | |
| Sunopta Inc | Mahes S. Wickramasinghe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 17,770 | 17,770 | - | - | Restricted Stock Units | |
| Sunopta Inc | David J. Lemmon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 17,770 | 17,770 | - | - | Restricted Stock Units | |
| Sunopta Inc | Leslie Starr Keating | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 17,770 | 17,770 | - | - | Restricted Stock Units | |
| Sunopta Inc | Rebecca Fisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 17,770 | 17,770 | - | - | Restricted Stock Units | |
| Sunopta Inc | Diego Reynoso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 17,770 | 17,770 | - | - | Restricted Stock Units | |
| Skyworks | Robert A. Schriesheim | Director, Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 17,266 | 17,266 | - | - | Restricted Stock Units | |
| Corning | Stefan Becker | SVP, Finance & Corp Controller | Sale of securities on an exchange or to another person at price $ 49.68 per share. | 29 May 2025 | 17,106 | 16,117 (0%) | 0% | 49.7 | 849,838 | Common Stock |
| Glatfelter Corp | Bruce Brown | Director | Purchase of securities on an exchange or from another person at price $ 11.81 per share. | 29 May 2025 | 16,940 | 17,228 (0%) | 0% | 11.8 | 199,983 | Common Stock, Par Value $.01 |
| Intuit | Laura A. Fennell | EVP, People and Places | Exercise or conversion of derivative security received from the company (such as an option) at price $ 525.51 per share. | 29 May 2025 | 16,671 | 39,466 (0%) | 0% | 525.5 | 8,760,777 | Common Stock |
| Intuit | Laura A. Fennell | EVP, People and Places | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 16,671 | 725 | - | - | Non-Qualified Stock Options (right to buy) | |
| Kyverna Therapeutics Inc | Beth C. Seidenberg | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 16,634 | 16,634 | - | 0 | Common Stock | |
| Kyverna Therapeutics Inc | Daniel K. Spiegelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 16,634 | 16,634 | - | 0 | Common Stock | |
| Kyverna Therapeutics Inc | Fred E. Cohen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 16,634 | 16,634 | - | 0 | Common Stock | |
| Kyverna Therapeutics Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 16,634 | 16,634 | - | 0 | Common Stock | |
| Kyverna Therapeutics Inc | Christi Shaw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 16,634 | 16,634 | - | 0 | Common Stock | |
| Kyverna Therapeutics Inc | Mert Aktar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 16,634 | 16,634 | - | 0 | Common Stock | |
| Hagerty Inc (Class A) | Robert I. Kauffman | Director | Sale of securities on an exchange or to another person at price $ 9.72 per share. | 29 May 2025 | 16,070 | 3,899,937 | - | 9.7 | 156,200 | Class A Common Stock |
| Seagate Tech | Gianluca Romano | EVP & CFO | Sale of securities on an exchange or to another person at price $ 117.17 per share. | 29 May 2025 | 15,918 | 47,182 (0%) | 0% | 117.2 | 1,865,091 | Ordinary Shares |
| Seagate Tech | Gianluca Romano | EVP & CFO | Sale of securities on an exchange or to another person at price $ 117.38 per share. | 29 May 2025 | 15,631 | 49,267 (0%) | 0% | 117.4 | 1,834,703 | Ordinary Shares |
| Williams-Sonoma | Laura J. Alber | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 163.82 per share. | 29 May 2025 | 15,481 | 1,008,245 (1%) | 0% | 163.8 | 2,536,097 | Common Stock |
| First Foundation Inc | Max A. Briggs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 15,210 | 39,004 (0%) | 0% | 0 | Common Stock | |
| First Foundation Inc | Jacob P. Sonenshine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 15,210 | 23,863 (0%) | 0% | 0 | Common Stock | |
| Getty Images Holdings Inc (Class A) | Mikael Cho | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 15,000 | 138,862 | - | 0 | Class A Common Stock | |
| Nautilus biotech Inc | Anna Mowry | CFO and Treasurer | Purchase of securities on an exchange or from another person at price $ 0.77 per share. | 29 May 2025 | 15,000 | 83,000 | - | 0.8 | 11,489 | Common Stock |
| Travelers Companies | Avrohom J. Kess | Vice Chmn & Chief Legal Off | Sale of securities on an exchange or to another person at price $ 274.15 per share. | 29 May 2025 | 14,796 | 50,855 (0%) | 0% | 274.2 | 4,056,366 | Common Stock |
| EverQuote Inc (Class A) | David B. Blundin | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 29 May 2025 | 14,153 | 379,115 (3%) | 0% | - | Class A Common Stock | |
| Travelers Companies | Alan D. Schnitzer | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 273.40 per share. | 29 May 2025 | 14,121 | 283,664 (0%) | 0% | 273.4 | 3,860,691 | Common Stock |
| Schrodinger Inc | Mannix Vartan Aklian | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 14,063 | 14,063 (0%) | 0% | 0 | Common Stock | |
| Acadia Pharma Inc | Laura A. Brege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 13,793 | 13,793 | - | - | Director Stock Options (Right to Buy) | |
| Acadia Pharma Inc | Daniel B. Soland | Director | 29 May 2025 | 13,793 | 13,793 | - | - | Director Stock Options (Right to Buy) | ||
| Acadia Pharma Inc | Edmund P. Harrigan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 13,793 | 13,793 | - | - | Director Stock Options (Right to Buy) | |
| Acadia Pharma Inc | James M. Daly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 13,793 | 13,793 | - | - | Director Stock Options (Right to Buy) | |
| Acadia Pharma Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 13,793 | 13,793 | - | - | Director Stock Options (Right to Buy) | |
| Acadia Pharma Inc | Adora Ndu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 13,793 | 13,793 | - | - | Director Stock Options (Right to Buy) | |
| Childrens Place Inc | Muhammad Umair | Director, PRESIDENT AND INTERIM CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. | 29 May 2025 | 13,544 | 110,524 (0%) | 0% | 6.0 | 81,670 | Common Stock, par value $0.10 per share |
| First Foundation Inc | Mitchell M. Rosenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 13,308 | 21,961 (0%) | 0% | 0 | Common Stock | |
| First Foundation Inc | Benjamin Mackovak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 13,308 | 13,308 (0%) | 0% | 0 | Common Stock | |
| First Foundation Inc | Elizabeth A. Pagliarini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 13,308 | 21,961 (0%) | 0% | 0 | Common Stock | |
| First Foundation Inc | Sam Edelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 13,308 | 13,308 (0%) | 0% | 0 | Common Stock | |
| Datacentrex Inc | Robert Haag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.00 per share. | 29 May 2025 | 12,500 | 312,476 | - | 4 | 50,000 | Common Stock |
| Travelers Companies | David Donnay Rowland | EVP & Co-Chief Invest. Officer | Sale of securities on an exchange or to another person at price $ 274.01 per share. | 29 May 2025 | 12,069 | 11,731 (0%) | 0% | 274.0 | 3,307,004 | Common Stock |
| Entergy | Kimberly A. Fontan | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 12,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Entergy | Kimberly A. Fontan | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.60 per share. | 29 May 2025 | 12,000 | 61,571 (0%) | 0% | 44.6 | 535,200 | Common Stock |
| United Community Banks Inc | Kenneth L. Daniels | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 29 May 2025 | 11,678 | 14,178 (0%) | 0% | 0 | Common Stock | |
| United Community Banks Inc | Kenneth L. Daniels | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 29 May 2025 | 11,678 | 8,916 (0%) | 0% | 0 | Common Stock | |
| Cheesecake Factory Inc | Scarlett May | EVP, GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.03 per share. | 29 May 2025 | 11,600 | 43,672 (0%) | 0% | 46.0 | 533,948 | Common Stock |
| Cheesecake Factory Inc | Scarlett May | EVP, GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 55.98 per share. | 29 May 2025 | 11,600 | 22,872 (0%) | 0% | 56.0 | 649,362 | Common Stock |
| Cheesecake Factory Inc | Scarlett May | EVP, GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 11,600 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Advantage Soln Inc (Class A) | James M. Kilts | Director | Purchase of securities on an exchange or from another person at price $ 1.28 per share. | 29 May 2025 | 11,400 | 1,283,099 | - | 1.3 | 14,570 | Class A Common Stock |
| Childrens Place Inc | Claudia Lima-Guinehut | BRAND PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. | 29 May 2025 | 11,335 | 77,635 (0%) | 0% | 6.0 | 68,350 | Common Stock, par value $0.10 per share |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Other type of transaction at price $ 0.00 per share. | 29 May 2025 | 11,200 | 22,949 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Elizabeth A. Gasser | EVP, Chief Strategy Officer | Other type of transaction at price $ 0.00 per share. | 29 May 2025 | 11,200 | 0 (0%) | 0% | 0 | Common Stock | |
| Seagate Tech | Gianluca Romano | EVP & CFO | Sale of securities on an exchange or to another person at price $ 117.86 per share. | 29 May 2025 | 11,185 | 38,082 (0%) | 0% | 117.9 | 1,318,236 | Ordinary Shares |
| Hagerty Inc (Class A) | Robert I. Kauffman | Director | Sale of securities on an exchange or to another person at price $ 9.80 per share. | 29 May 2025 | 11,112 | 3,888,825 | - | 9.8 | 108,898 | Class A Common Stock |
| Edesa Biotech Inc | Joan Chypyha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 11,000 | 11,029 (0%) | 0% | 0 | Common Shares | |
| Edesa Biotech Inc | Patrick Marshall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 11,000 | 52,666 (0%) | 0% | 0 | Common Shares | |
| Edesa Biotech Inc | Chuck V. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 11,000 | 11,000 (0%) | 0% | 0 | Common Shares | |
| Longeveron Inc (Class A) | Rock Soffer | Director | Sale of securities on an exchange or to another person at price $ 1.25 per share. | 29 May 2025 | 11,000 | 209,034 | - | 1.3 | 13,750 | Class A Common Stock |
| Rush Street Interactive Inc (Class A) | Daniel W. Yih | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 10,958 | 181,678 | - | 0 | Class A Common Stock | |
| Rush Street Interactive Inc (Class A) | Niccolo Mcleod de Masi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 10,958 | 15,203 | - | 0 | Class A Common Stock | |
| Rush Street Interactive Inc (Class A) | Jack A. Markell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 10,958 | 12,821 | - | 0 | Class A Common Stock | |
| Rush Street Interactive Inc (Class A) | Leslie Bluhm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 10,958 | 111,629 | - | 0 | Class A Common Stock | |
| Rush Street Interactive Inc (Class A) | Judith Gold | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 10,958 | 111,629 | - | 0 | Class A Common Stock | |
| Rush Street Interactive Inc (Class A) | James Gordon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 10,958 | 111,629 | - | 0 | Class A Common Stock | |
| Rush Street Interactive Inc (Class A) | Thomas Winter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 10,958 | 15,825 | - | 0 | Class A Common Stock | |
| Rush Street Interactive Inc (Class A) | Andrew G. Bluhm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 10,958 | 12,821 | - | 0 | Class A Common Stock | |
| Entergy | Kimberly A. Fontan | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 10,890 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Entergy | Kimberly A. Fontan | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.94 per share. | 29 May 2025 | 10,890 | 72,461 (0%) | 0% | 47.9 | 522,067 | Common Stock |
| Montana Tech Corp (Class A) | Paul M. Dabbar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 10,800 | 0 | - | - | Restricted Stock Units | |
| Montana Tech Corp (Class A) | Paul M. Dabbar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 10,800 | 105,407 | - | 0 | Class A Common Stock | |
| Acadia Healthcare Co Inc | Reeve B. Waud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 10,637 | 59,952 (0%) | 0% | 0 | Common Stock | |
| Microstrategy Inc (Class A) | Jarrod M. Patten | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 10,300 | 0 | - | - | Director Stock Option (Right to buy) | |
| Microstrategy Inc (Class A) | Jarrod M. Patten | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.60 per share. | 29 May 2025 | 10,300 | 34,170 (0%) | 0% | 17.6 | 181,259 | Class A Common Stock |
| Grove Collaborative Holdings Inc (Class A) | Jeffrey Yurcisin | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 29 May 2025 | 10,000 | 347,307 | - | 1.3 | 13,335 | Class A Common Stock |
| Datacentrex Inc | Joanna D. Massey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.00 per share. | 29 May 2025 | 10,000 | 20,592 | - | 4 | 40,000 | Common Stock |
| Mativ Holdings Inc | Kimberly E. Ritrievi | Director | Purchase of securities on an exchange or from another person at price $ 5.88 per share. | 29 May 2025 | 10,000 | 30,640 (0%) | 0% | 5.9 | 58,800 | Common Stock |
| Savara Inc | Joseph S. McCracken | Director | Purchase of securities on an exchange or from another person at price $ 2.08 per share. | 29 May 2025 | 10,000 | 260,837 (0%) | 0% | 2.1 | 20,825 | Common Stock |
| Longeveron Inc (Class A) | Rock Soffer | Director | Sale of securities on an exchange or to another person at price $ 1.30 per share. | 29 May 2025 | 10,000 | 220,034 | - | 1.3 | 13,000 | Class A Common Stock |
| Exelixis Inc | George H. Poste | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 9,812 | 178,832 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Jack L. Wyszomierski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 9,812 | 366,417 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Stelios Papadopoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 9,812 | 1,289,228 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Mary C. Beckerle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 9,812 | 40,218 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Maria C. Freire | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 9,812 | 100,819 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Julie Anne Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 9,812 | 20,590 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Bob Oliver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 9,812 | 43,326 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Tomas J. Heyman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 9,812 | 42,282 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Sue Gail Eckhardt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 9,812 | 40,218 (0%) | 0% | 0 | Common Stock | |
| PJT Partners Inc (Class A) | Kievdi Don Cornwell | Director | Sale of securities on an exchange or to another person at price $ 151.08 per share. | 29 May 2025 | 9,597 | 19,250 (0%) | 0% | 151.1 | 1,449,915 | Class A Common Stock |
| Acadia Pharma Inc | Laura A. Brege | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 9,387 | 0 | - | - | Restricted Stock Units | |
| Acadia Pharma Inc | Laura A. Brege | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 9,387 | 29,541 (0%) | 0% | - | Common Stock | |
| Acadia Pharma Inc | Daniel B. Soland | Director | 29 May 2025 | 9,387 | 0 | - | - | Restricted Stock Units | ||
| Acadia Pharma Inc | Daniel B. Soland | Director | 29 May 2025 | 9,387 | 44,041 (0%) | 0% | - | Common Stock | ||
| Acadia Pharma Inc | Edmund P. Harrigan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 9,387 | 35,041 (0%) | 0% | - | Common Stock | |
| Acadia Pharma Inc | Edmund P. Harrigan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 9,387 | 0 | - | - | Restricted Stock Units | |
| Acadia Pharma Inc | James M. Daly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 9,387 | 0 | - | - | Restricted Stock Units |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.